Adiponectin and future coronary heart disease events among men with type 2 diabetes
about
sameAs
Adiponectin, driver or passenger on the road to insulin sensitivity?Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significanceADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease?Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesDiabetic cardiomyopathy: signaling defects and therapeutic approachesEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsAdiponectin and cardiovascular disease: state of the art?Obesity, inflammation, and lung injury (OILI): the good.Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years.Fetuin-A induces cytokine expression and suppresses adiponectin production.Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors.Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes.Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.Lipotoxicity in the heart.Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function.Adipokines, insulin resistance, and coronary artery calcification.Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetesEGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes.Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.Adiponectin actions in the cardiovascular system.Cardiac remodeling in obesity.Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes.The role of adiponectin in cancer: a review of current evidence.Effects of sleep restriction on adiponectin levels in healthy men and women.Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome.Adiponectin: a link between obesity and cancer.Association between adiponectin concentrations and cardiovascular disease in diabetic patients: a systematic review and meta-analysis.Effects of niacin on atherosclerosis and vascular function.Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients.Inflammatory concepts of obesity.Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.Effect of weight loss on adipokine levels in obese patients.Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study.Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants.Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in womenRelation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load.Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 DiabetesNiacin in cardiovascular disease: recent preclinical and clinical developments
P2860
Q26827971-3AF72679-5A76-481A-90BF-23E4EC7D633EQ26865140-E80326D6-D2ED-4878-A5F7-C39535B22DF4Q26866336-C9C12FCA-ABD8-4E76-9C14-F01A379823E6Q27002459-A9DEF0CB-CA77-433A-94EC-932C54F3F850Q27008359-742CA109-D8D8-4ECF-88B1-EE0592820B71Q28395852-74F01F11-61D1-4999-8BEB-320900BEF28FQ28730724-A76A7A89-A772-4B88-9A3A-AAD4F249FF51Q30358456-E848A350-87A4-4A11-9244-B3085BB77815Q30363313-453601E7-A1EF-42DC-8FC5-41891379CD00Q31146255-A9178980-F2BC-4A10-9AB4-6456F7B2A2A2Q33323370-78870798-DA35-4FDD-B2E5-8320FA2B96E1Q33593051-9D69D4E1-9940-491B-ACD2-EA372AABF9F5Q33628211-918B1A82-A835-4502-9499-B3591143ED6AQ33628233-56A6A6CF-FA58-486C-99B3-492D9608653EQ33665107-5D674326-0580-47A2-9279-0EFBC3BCDF4BQ33686101-6F28530B-DD88-4998-BD92-2A771186A01CQ33785169-DE2EBBD1-0EA5-443C-A91D-F6D3D615AA3FQ33803486-3B83F81A-D885-4C03-95A0-53C062CE9091Q33926875-B11512EF-37D6-4208-89B8-2E6E6ABA8EE4Q33945028-0E931455-CD24-43A9-92C3-6A87A4120CD8Q34001251-3746DA1E-A73F-48F7-8ECF-B77FA485C30AQ34043589-F0054B6E-F824-40DA-8FA3-BF4D1832CBB9Q34230412-A99334B7-D785-4A5C-8AE1-CB48AB674725Q34271986-638A4490-D97E-4FE1-934E-D01F58FEFDF5Q34288038-DCEDC7A1-5CD0-4AC8-9D8C-0330D42516CEQ34461362-C041D3F9-8F3A-4C09-8859-47F072E6DD7BQ34549919-EC4F9DD3-6956-4561-AD56-E071A21A32ECQ35040943-78C2A46F-F285-4E7B-B556-42C6DE3FB42AQ35132366-F7710109-229C-4EBD-B59A-9AD62360BCCBQ35141900-7CDBA471-07B6-45E3-8A1F-F4962B4EE2B4Q35151595-02C77B13-95C6-4617-BAED-4F78A11AEB3BQ35176441-34414970-DECF-4594-8DF9-F33B4CFBF868Q35178805-170089EE-12DA-455F-8A48-9A34BF0012B7Q35208155-EB226B8A-8F74-4A3F-8225-E3D3460466EFQ35213584-37510F59-8518-45AC-AC93-51F07481C012Q35501308-AA31785A-C102-45DE-8DF1-61E2D75F5FF0Q35663986-9E1BD82F-E270-457B-8BA1-5A4A968AFF5BQ35893643-ECAAB685-4651-4537-944B-CA4F2936B671Q35932408-CA8A1C9C-FCFD-4F59-B6D4-535E717E79C3Q36084389-A54582B2-1D54-47BC-A1CA-89BDA360400E
P2860
Adiponectin and future coronary heart disease events among men with type 2 diabetes
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@ast
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@en
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@nl
type
label
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@ast
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@en
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@nl
prefLabel
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@ast
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@en
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@nl
P50
P3181
P1433
P1476
Adiponectin and future coronary heart disease events among men with type 2 diabetes
@en
P2093
P3181
P356
10.2337/DIABETES.54.2.534
P407
P577
2005-02-01T00:00:00Z